Understanding how to regrow lost or damaged body tissues
New upstream targets for HIF-1a-mediated regeneration in young and aged animals
This research explores how to encourage the body to naturally regrow its own tissues, like bone and cartilage, by activating a special pathway.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lankenau Institute for Medical Research NIH-funded |
| Lab location | 1 site (Wynnewood, United States) |
| Project ID | NIH-11099990 on NIH RePORTER |
What this research studies
We are looking for ways to help the body regenerate lost or damaged tissues, similar to how some animals like newts can regrow limbs. Our work focuses on a natural pathway in the body called HIF-1α, which we've found plays a key role in regeneration in certain mice. By using special materials and a compound called AMD3100, we aim to activate this pathway to encourage the body to heal itself. This approach could potentially lead to new ways for people to recover from injuries or diseases that cause tissue loss.
Who could benefit from this research
Good fit: This foundational research is not directly recruiting patients, but future studies stemming from this work might benefit individuals with significant tissue loss or damage due to injury or disease.
Not a fit: Patients without tissue damage or those seeking immediate clinical solutions would not directly benefit from this early-stage laboratory research.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that help people regrow their own damaged or lost tissues, such as bone or cartilage, without needing transplants or artificial replacements.
How similar studies have performed: This research builds upon nearly 25 years of observations in regenerative mice models, identifying the HIF-1α pathway as a central regulator of regeneration.
Where this research is happening
Wynnewood, United States
- Lankenau Institute for Medical Research — Wynnewood, United States (Active)
Researchers
- Principal investigator: Heber-Katz, Ellen S. — Lankenau Institute for Medical Research
- Study coordinator: Heber-Katz, Ellen S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.